EVIO (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, has recently grown its top-tier management team by two former executives of Pfizer and Quest Diagnostics. The company’s recently appointed president Al Lustig fills the role of driving EVIO’s growth in new and current markets through sales and operational strategies. As the recently appointed Vice President of Operations, Ron Russak will focus on scaling existing and new laboratory operations to increase growth and profitability. Additionally, EVIO this morning announced financial and operating results for the first quarter of 2018 ended December 31, 2017. Among other highlights, first quarter revenue was $946,865, up 41.6% from the same period of the previous year. Gross profit showed a 168% increase over the first quarter of last year, totaling $210,602 for the first quarter 2018. “We are pleased with our first quarter results, especially with the year over year increase in activity in Oregon. The company is continuing to focus on laying a strong foundation to build upon,” EVIO chairman and CEO William Waldrop stated in the news release.
About EVIO, Inc.
EVIO, Inc. is a life sciences company focused on analyzing cannabis as a means for improving quality of life. The Company provides analytical testing services, advisory services and performs product research in its accredited laboratory testing facilities. The Company’s EVIO Labs division operating coast-to-coast provides state-mandated ancillary services to ensure the safety and quality of the nation’s cannabis supply. For more information, visit www.EvioLabs.com.
More from CannabisNewsBreaks
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.CannabisNewsWire.com